How to buy Opko Health stock (OPK)

Opko Health is a diagnostics & research business based in the US. Opko Health shares (OPK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.60 – an increase of 2.56% over the previous week. Opko Health employs 3,930 staff and has a trailing 12-month revenue of around $711.4 million.

Our top picks for where to buy Opko Health stock

Buy Opko Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Opko Health stock price (NASDAQ: OPK)

Use our graph to track the performance of OPK stocks over time.

Opko Health shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$1.60
52-week range	$0.85 - $1.75
50-day moving average more info button	$1.52
200-day moving average more info button	$1.38
Wall St. target price	$3.96
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.19

Is it a good time to buy Opko Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Opko Health price performance over time

Historical closes compared with the close of $1.59 from 2024-12-13

1 week (2024-12-09)	0.63%
1 month (2024-11-15)	-3.05%
3 months (2024-09-16)	-3.05%
6 months (2024-06-14)	27.20%

1 year (2023-12-15)	2.91%
2 years (2022-12-16)	27.20%
3 years (2021-12-16)	3.99
5 years (2019-12-16)	0.63%

Opko Health financials

Revenue TTM	$711.4 million
Gross profit TTM	$214.3 million
Return on assets TTM	-8.97%
Return on equity TTM	-9.39%
Profit margin	-18.8%
Book value	$2.06
Market Capitalization more info button	$1.1 billion

TTM: trailing 12 months

Opko Health share dividends

We're not expecting Opko Health to pay a dividend over the next 12 months.

Opko Health share price volatility

Over the last 12 months, Opko Health's shares have ranged in value from as little as $0.8516 up to $1.745. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Opko Health's is 1.647. This would suggest that Opko Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Opko Health overview

OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico.

Frequently asked questions

What percentage of Opko Health is owned by insiders or institutions?
Currently 54.467% of Opko Health shares are held by insiders and 28.03% by institutions. How many people work for Opko Health?
Latest data suggests 3,930 work at Opko Health. When does the fiscal year end for Opko Health?
Opko Health's fiscal year ends in December. Where is Opko Health based?
Opko Health's address is: 4400 Biscayne Boulevard, Miami, FL, United States, 33137 What is Opko Health's ISIN number?
Opko Health's international securities identification number is: US68375N1037 What is Opko Health's CUSIP number?
Opko Health's Committee on Uniform Securities Identification Procedures number is: 23282G105